Thioredoxin overexpressin prevents NO-induced reduction of NO synthase activity in lung endothelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 275, Issue 2 19-2, 1998, Pages

  Zhang, Jianliang ^a   Li, Yong D ^a   Patel, Jawaharlal M ^a   Block, Edward R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Gene expression; Lung endothelium; Nitric oxide; Thioredoxin reductase

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REGULATOR PROTEIN; THIOREDOXIN; THIOREDOXIN REDUCTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAREDOXIN; MESSENGER RNA; NOS3 PROTEIN, HUMAN; OXIDOREDUCTASE; PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CELL LEVEL; DNA TRANSFECTION; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ASSAY; ENZYME SYNTHESIS; LUNG ARTERY; LUNG ENDOTHELIUM; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; PULMONARY ARTERY; SWINE; VASCULAR ENDOTHELIUM;

ANIMALS; CELLS, CULTURED; CLONING, MOLECULAR; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OXIDOREDUCTASES; PROTEINS; PULMONARY ARTERY; RECOMBINANT PROTEINS; RNA, MESSENGER; SWINE; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH); TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0032134429     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.275.2.l288     Document Type: Article

References (41)

1. Abate, C., L. Patel, F. J. Rauscher, and T. Curran. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249: 1157-1161, 1990.
2. Adnot, S., B. Raffestin, and S. Eddahibi. NO in the lung. Respir. Physiol. 101: 109-120, 1995.
3. Arnelle, D. R., and J. S. Stamler. NO+, NO, and NO-donation by S-nitrosothiol: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch. Biochem. Biophys. 318: 279-285, 1995.
4. Barnes, P. J., and M. G. Belvisi. Nitric oxide and lung disease. Thorax 48: 1034-1043, 1993.
5. Bhat, G. B., S. B. Tinsley, J. K. Toison, J. M. Patel, and E. R. Block. Hypoxia increases the susceptibility of pulmonary artery endothelial cells to hydrogen peroxide injury. J. Cell. Physiol. 151: 228-238, 1992.
6. Clancy, R. M., D. Levartovsky, J. Leszcynska-Piziak, J. Yegudin, and S. B. Abramson. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils; evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. USA 91: 3680-3684, 1994.
7. Curran, R. D., F. K. Ferrari, P. H. Kispert, J. Stadler, D. J. Stuehr, R. L. Simmons, and T. R. Billiar. Nitric oxide and nitric oxide generating compounds inhibits hepatocyte protein synthesis. FASEB J. 5: 2085-2092, 1991.
8. Davies, M. G., G. J. Fulton, and P. O. Hagen. Clinical biology of nitric oxide. Br. J. Surg. 82: 1598-1610, 1995.
9. Feinberg, A. P., and B. Vogelstein. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132: 6-13, 1983.
10. Gan, Z., and W. W. Wells. Purification and properties of thioltransferase. J. Biol. Chem. 261: 996-1001, 1986.
11. Gopalakrishna, R., Z. H. Chen, and U. Gundimeda. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268: 27180-27185, 1993.
12. Griffith, O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinyl pyridine. Anal. Biochem. 106: 207-212, 1980.
13. Hayashi, T., Y. Ueno, and T. Okamoto. Oxidoreductive regulation of nuclear factor κB: involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268: 11380-11388, 1993.
14. Henderson, S. A., P. H. Lee, E. E. Aeberhard, J. W. Adams, L. J. Ignaro, W. J. Murphy, and M. P. Sharman. Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. J. Biol. Chem. 269: 25239-25242, 1994.
15. Holmgren, A. Thioredoxin. Annu. Rev. Biochem. 54: 305-329, 1985.
16. Holmgren, A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264: 13963-13966, 1989.
17. Holmgren, A. Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide. Structure 3: 239-243, 1995.
18. Kaghad, M., F. Dessarps, H. Jacquemin-Sablon, D. Caput, D. Fradelizi, and E. E. Wollman. Genomic cloning of human thioredoxin-encoding gene: mapping of the transcription start point and analysis of the promoter. Gene 140: 273-278, 1994.
19. Knowles, R. G., and S. Moncada. Nitric oxide synthases in mammals. Biochem. J. 298: 249-258, 1994.
20. Kubes, P., and D. N. Granger. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H611-H615, 1992.
21. 2-exposed pulmonary artery endothelial cells. Free Radic. Biol. Med. 23: 120-126, 1997.
22. Lipton, S. A., and J. S. Stamler. Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33: 1229-1233, 1994.
23. Lowry, O. H., N. J. Rosenbrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
24. Ma, X. L., B. L. Lopez, T. A. Christopher, D. S. Birenbaum, and J. Vinten-Johansen. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H2045-H2051, 1996.
25. Matthews, J. R., N. Wakasugi, J. L. Virelizier, J. Yodoi, and R. T. Hay. Thioredoxin regulates the DNA binding activity of Nf-κB by reduction of a disulfide bond involving cysteine 62. Nucleic Acids Res. 20: 3821-3830, 1992.
26. Mohr, S., J. S. Stamler, and B. Brune. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J. Biol. Chem. 271: 4209-4214, 1996.
27. Nguyen, T., D. Brunson, C. L. Crespi, B. W. Penman, J. S. Wishnok, and S. R. Tannenbaum. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89: 3030-3034, 1992.
28. Oblong, J. E., P. Gasdaska, K. Sherrill, and G. Powis. Purification of human thioredoxin reductase: properties and characterization by absorption and circular dichroism spectroscopy. Biochemistry 32: 7271-7277, 1993.
29. Oka, M., M. Ohnishi, H. Takahashi, S. Soma, K. Hasunuma, K. Sato, and S. Kira. Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L419-L424, 1996.
30. Palmer, R. M. J., L. Bridge, N. A. Foxwell, and S. Moncada. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br. J. Pharmacol. 105: 11-12, 1992.
31. Patel, J. M., A. J. Abeles, and E. R. Block. Nitric oxide exposure and sulfhydryl modulation alter L-arginine transport in cultured pulmonary artery endothelial cells. Free Radic. Biol. Med. 20: 629-637, 1996.
32. Patel, J. M., and E. R. Block. Sulfhydryl-disulfide modulation and the role of disulfide oxidoreductases in regulation of the catalytic activity of nitric oxide synthase in pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 13: 352-359, 1995.
33. Patel, J. M., J. L. Zhang, and E. R. Block. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of thioredoxin in regulation of catalytic activity. Am. J. Respir. Cell Mol. Biol. 15: 410-419, 1996.
34. Powis, G., M. Briehl, and J. Oblong. Redox signaling and control of cell growth and death. Pharmacol. Ther. 68: 149-173, 1995.
35. Sarkan, R., R. C. Webb, and J. C. Stanley. Nitric oxide inhibition of endothelial cell mitogenesis and proliferation. Surgery 118: 274-279, 1995.
36. Schmitz, G. G., T. Walter, R. Seibl, and C. Kessler. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal. Biochem. 192: 222-231, 1991.
37. Stamler, J. S. Redox signaling nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994.
38. Winer, B. J. Statistical Principals in Experimental Design. New York: McGraw-Hill; 1971, p. 210-219.
39. 2 reaction. Chem. Res. Toxicol. 7: 519-525, 1994.
40. Yoshizumi, M., M. A. Perrella, J. C. Burnett, Jr., and M. E. Lee. Tumor necrosis factor down regulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205-209, 1993.
41. Zhang, J. L., J. M. Patel, Y. D. Li, and E. R. Block. Reductase domain cysteines 1048 and 1114 are critical for catalytic activity of human endothelial cell nitric oxide synthase as probed by site-directed mutagenesis. Biochem. Biophys. Res. Commun. 226: 293-300, 1996.